Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Ko

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Nature Cancer|January 2, 2026
Tumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus chemoradiotherapy in head and neck cancerNadeem Riaz, Tyler J Alban, Robert I Haddad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2018
Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti-PD-1 Therapies in Metastatic MelanomaDouglas B Johnson, Jennifer Bordeaux, Ju Young Kim, et al.
The American Journal of Surgical Pathology|March 25, 2024
BRAF Mutated and Morphologically Spitzoid Tumors, a Subgroup of Melanocytic Neoplasms Difficult to Distinguish From True Spitz NeoplasmsPedram Gerami, Alice Chen, Natasha Sharma, et al.
Human Pathology|March 14, 2026
The Impact of Next Generation Sequencing Studies on the Diagnosis of BAP1 Inactivated Melanocytic TumorsJonathan Braat, Nithya Sai Trichy, Lindsay Jeanne Holic, et al.
JAMA Network Open|January 11, 2023
Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions: A Consensus StatementRaymond L Barnhill, David E Elder, Michael W Piepkorn, et al.
Pigment Cell & Melanoma Research|July 25, 2022
Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL studyLi Luo, Ronglai Shen, Arshi Arora, et al.
JCO Precision Oncology|November 7, 2024
DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic SignificanceKathleen Conway, Sharon N Edmiston, Amanda Vondras, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2025
Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III MelanomaJennifer M Wiggins, Qiao Zhang, Yian Zhang, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Nature Cancer|January 2, 2026
Tumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus chemoradiotherapy in head and neck cancerNadeem Riaz, Tyler J Alban, Robert I Haddad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2018
Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti-PD-1 Therapies in Metastatic MelanomaDouglas B Johnson, Jennifer Bordeaux, Ju Young Kim, et al.
The American Journal of Surgical Pathology|March 25, 2024
BRAF Mutated and Morphologically Spitzoid Tumors, a Subgroup of Melanocytic Neoplasms Difficult to Distinguish From True Spitz NeoplasmsPedram Gerami, Alice Chen, Natasha Sharma, et al.
Human Pathology|March 14, 2026
The Impact of Next Generation Sequencing Studies on the Diagnosis of BAP1 Inactivated Melanocytic TumorsJonathan Braat, Nithya Sai Trichy, Lindsay Jeanne Holic, et al.
JAMA Network Open|January 11, 2023
Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions: A Consensus StatementRaymond L Barnhill, David E Elder, Michael W Piepkorn, et al.
Pigment Cell & Melanoma Research|July 25, 2022
Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL studyLi Luo, Ronglai Shen, Arshi Arora, et al.
JCO Precision Oncology|November 7, 2024
DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic SignificanceKathleen Conway, Sharon N Edmiston, Amanda Vondras, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2025
Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III MelanomaJennifer M Wiggins, Qiao Zhang, Yian Zhang, et al.
Pageof 6